Medical Supply Chain Resiliency Act

The Medical Supply Chain Resiliency Act (S 998) aims to strengthen U.S. access to critical medical goods by creating "trusted trade partner agreements" with foreign countries that meet specific criteria, such as maintaining open trade during health emergencies and protecting intellectual property. It directly affects the U.S. Trade Representative, foreign governments, and medical manufacturers by reducing tariffs and trade barriers for medical devices and pharmaceuticals with these partners. Key mechanisms include establishing a framework to diversify supplier networks, harmonize regulatory standards, and expedite cross-border movement of medical goods during crises. The bill requires the President to submit regular reports to Congress and mandates that agreements must be approved by Congress before taking effect.